Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.
Peter JirakRudin PistulliMichael LichtenauerBernhard WernlyVera PaarLukas J MotlochRichard RezarChristian JungUta C HoppeP Christian SchulzeDaniel KretzschmarRüdiger C Braun-DullaeusTarek BekfaniPublished in: Journal of clinical medicine (2020)
Based on their differences in secretion patterns, novel cardiovascular biomarkers might represent a promising diagnostic tool for HFpEF in the future.